网络分析信号检测:网络权重归一化在心血管药物安全中的应用
研究开发了基于网络理论的NEWS评分,通过将报告加权网络中每条边的权重除以拓扑加权网络中同一条边的权重进行归一化,并在EudraVigilance的72,475份心血管不良事件ICSR中比较NEWS评分与ROR的信号检测性能,发现药物型NEWS评分在四种不良事件中优于ROR。
要点
- NEWSD评分在急性心肌梗死、心律失常、肺动脉高压和QT延长中AUROC均优于ROR。
- 研究纳入EudraVigilance中五种心血管不良事件的72,475份ICSR。
- 信号检测确认率仅2.1%,开发网络理论指标旨在提高确认信号比例。
核心结论
- 基于报告加权并由共报告药物拓扑加权归一化的NEWSD评分,在四种心血管不良事件中信号检测性能优于ROR。
研究设计与样本
- 从EudraVigilance获取五种心血管不良事件的ICSR,共纳入72,475份报告,开发Vigilace™网络分析应用并计算三种NEWS评分,用AUROC比较NEWS评分与ROR。
主要发现
- 药物型NEWS评分在急性心肌梗死(AUROC 0.856 vs. 0.720)、心律失常(0.657 vs. 0.614)、肺动脉高压(0.861 vs. 0.720)和QT延长(0.830 vs. 0.749)中优于ROR,DeLong检验p值<0.05。
- 体位性心动过速综合征因缺乏参考数据被排除。
关键数值与推荐
- 信号检测的确认信号比例仅为2.1%。
- NEWSD评分在四种不良事件中AUROC优于ROR,DeLong检验p值<0.05。
临床怎么用
- 临床药学智能体可参考NEWSD评分作为心血管药物不良反应信号检测的补充工具,但需结合临床判断。
局限性
- 体位性心动过速综合征因缺乏参考数据未能评估。
- 研究仅纳入五种心血管不良事件,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Signal detection yields confirmed signals in only 2.1%, which imposes a heavy burden on the pharmacovigilance system in the European Union. OBJECTIVES: We aimed to develop a network theoretical metric to increase the confirmed signal ratio of individual case safety report (ICSR) networks. METHODS: ICSRs of five cardiovascular adverse events were requested from EudraVigilance. We developed Vigilace™, a web-based application to build network representation of ICSRs. Three network-based signal scores, which we termed NEWS (normalized edge weight for signals) scores, were calculated by normalizing the weight of each edge in the report-based weighted network by the weight of the same edge in topological weighted networks. Depending on the third node in topological network edges, we defined full-, adverse event-, and drug-type NEWS scores. Area under the receiver operating characteristic curves (AUROC) were analyzed to compare the reporting odds ratio (ROR) and NEWS scores. RESULTS: Overall, 72,475 ICSRs were accessed from EudraVigilance. Drug-type NEWS (NEWSD) score performed better (DeLong test, p-value <0.05) compared with the ROR in case of four adverse events: acute myocardial infarction (AUROC: 0.856 vs. 0.720), arrhythmia (0.657 vs. 0.614), pulmonary hypertension (0.861 vs. 0.720), and QT prolongation (0.830 vs. 0.749). Postural orthostatic tachycardia syndrome was excluded due to the lack of reference data. CONCLUSION: This is the first demonstration that report-based weighting normalized by topological weighting of co-reported drugs, which we termed as NEWSD score, can perform better compared with the ROR. An application was developed for ICSR network analysis that facilitates the calculation of this score.
引用
- Pétervári M, Benczik B, Balogh OM, et al. Network Analysis for Signal Detection in Spontaneous Adverse Event Reporting Database: Application of Network Weighting Normalization to Characterize Cardiovascular Drug Safety. Drug Saf. 2022. PMID: 36198930. doi:10.1007/s40264-022-01225-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。